Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Evoke Pharma, Inc. - Common Stock (NQ:EVOK)

10.66 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Nov 4, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,304
Open 10.66
Bid (Size) 10.70 (900)
Ask (Size) 10.73 (200)
Prev. Close 10.66
Today's Range 10.66 - 10.66
52wk Range 1.940 - 10.79
Shares Outstanding 3,343,070
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
EVOK Stock Doubled In Value Today Post QOL Medical Deal, But Still Fails To Hit $11 Mark
Via Stocktwits
Gold Falls Over 1%; Uber Shares Decline After Q3 Results
 
Via Benzinga

Performance

YTD
+138.5%
+138.5%
1 Month
+127.8%
+127.8%
3 Month
+95.6%
+95.6%
6 Month
+223.0%
+223.0%
1 Year
+86.4%
+86.4%

More News

Read More
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Evoke Pharma Rockets On Grabbing 140% Premium In Acquisition Deal
Via Benzinga
EVOK Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Evoke Pharma, Inc. is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
Dow Dips Over 400 Points; Pfizer Earnings Top Estimates
Via Benzinga
Topics Stocks
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Wondering what's happening in today's pre-market session?
Via Chartmill
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Thursday's after hours session: top gainers and losers
Via Chartmill
These stocks that are showing activity before the opening bell on Thursday.
Via Chartmill
5 Healthcare Stocks On Fire This Week
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Evoke Pharma Posts 47 Percent Q2 Growth
Via The Motley Fool
Evoke Pharma Stock Skyrockets On Patent For Nasal Spray That Eases Stomach Delays; Retail Bulls Pile In
Via Stocktwits
Topics Intellectual Property
Crude Oil Moves Higher; RxSight Shares Plunge
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Evoke Pharma (EVOK) Shares Skyrocket On New Patent: What's Going On?
Via Benzinga
Topics Intellectual Property
Dow Jumps 200 Points; US Wholesale Inventories Fall 0.3% In May
Via Benzinga
Topics Stocks
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Earnings Scheduled For March 13, 2025
Via Benzinga

Frequently Asked Questions

Is Evoke Pharma, Inc. - Common Stock publicly traded?
Yes, Evoke Pharma, Inc. - Common Stock is publicly traded.
What exchange does Evoke Pharma, Inc. - Common Stock trade on?
Evoke Pharma, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Evoke Pharma, Inc. - Common Stock?
The ticker symbol for Evoke Pharma, Inc. - Common Stock is EVOK on the Nasdaq Stock Market
What is the current price of Evoke Pharma, Inc. - Common Stock?
The current price of Evoke Pharma, Inc. - Common Stock is 10.66
When was Evoke Pharma, Inc. - Common Stock last traded?
The last trade of Evoke Pharma, Inc. - Common Stock was at 11/04/25 04:00 PM ET
What is the market capitalization of Evoke Pharma, Inc. - Common Stock?
The market capitalization of Evoke Pharma, Inc. - Common Stock is 35.64M
How many shares of Evoke Pharma, Inc. - Common Stock are outstanding?
Evoke Pharma, Inc. - Common Stock has 36M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.